Guangzhou Wondfo Biotech Overview

  • Year Founded
  • 1992

Year Founded

  • Status
  • Public

  • Employees
  • 2,443

Employees

  • Stock Symbol
  • 300482

Stock Symbol

  • Investments
  • 11

  • Share Price
  • $2.15
  • (As of Friday Closing)

Guangzhou Wondfo Biotech General Information

Description

Guangzhou Wondfo Biotech Co Ltd is engaged in the research, development, production and sales of POCT-related products such as rapid diagnostic reagents and rapid testing instruments. Its products are sold in various countries and regions, and are widely used in clinical testing, critical care, chronic disease management, primary healthcare, epidemic monitoring, disaster relief, on-site law enforcement, and family and personal health management.

Contact Information

Website
www.wondfo.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Number 8 Lizhishan Road, Science City
  • Luogang District
  • Guangzhou, Guangdong 510641
  • China
+86 400
Primary Industry
Other Healthcare Technology Systems
Other Industries
Diagnostic Equipment
Stock Exchange
SHE
Vertical(s)
Corporate Office
  • Number 8 Lizhishan Road, Science City
  • Luogang District
  • Guangzhou, Guangdong 510641
  • China
+86 400

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Guangzhou Wondfo Biotech Stock Performance

As of 20-Nov-2026, Guangzhou Wondfo Biotech’s stock price is $2.15. Its current market cap is $1.01B with 468M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.15 $2.25 $2.14 - $3.77 $1.01B 468M 5.12M -$0.02

Guangzhou Wondfo Biotech Financials Summary

As of 30-Sep-2026, Guangzhou Wondfo Biotech has a trailing 12-month revenue of $285M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 958,102 1,184,783 1,281,796 1,707,171
Revenue 285,164 290,187 427,124 390,807
EBITDA (3,584) 23,951 127,328 115,931
Net Income (9,123) (8,764) 78,271 68,923
Total Assets 900,709 943,542 980,076 814,225
Total Debt 1,476 85,991 81,022 84,578
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Guangzhou Wondfo Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Guangzhou Wondfo Biotech‘s full profile, request access.

Request a free trial

Guangzhou Wondfo Biotech Patents

Guangzhou Wondfo Biotech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026016918-A1 Nucleic acid test cartridge Pending 15-Jul-2024
WO-2026016920-A1 Nucleic acid test cartridge and nucleic acid test method Pending 15-Jul-2024
WO-2025189788-A1 Incubation device and chemiluminescence immunoassay analyzer Pending 13-Mar-2024
WO-2025189789-A1 Incubation reaction device and in-vitro diagnosis analysis system Pending 13-Mar-2024
WO-2025189790-A1 Sample analyzer, loading device and temporary-storage mechanism Pending 11-Mar-2024 G01N35/025
To view Guangzhou Wondfo Biotech’s complete patent history, request access »

Guangzhou Wondfo Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Guangzhou Wondfo Biotech Investments & Acquisitions (11)

Guangzhou Wondfo Biotech’s most recent deal was a Early Stage VC with PolySeq for . The deal was made on 16-Mar-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
PolySeq 16-Mar-2026 Early Stage VC Enterprise Systems (Healthcare)
PolySeq 12-May-2023 Early Stage VC Enterprise Systems (Healthcare)
Tisenc 29-Jan-2022 Merger/Acquisition Diagnostic Equipment
Jiaohong Biotech 05-Aug-2021 Early Stage VC Diagnostic Equipment
Cells Vision 11-Jun-2021 Early Stage VC Decision/Risk Analysis
You’re viewing 5 of 11 investments and acquisitions. Get the full list »

Guangzhou Wondfo Biotech ESG

Risk Overview

Risk Rating

Updated October, 31, 2025

33.18 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,999

Rank

Percentile

Healthcare

Industry

of 665

Rank

Percentile

Medical Devices

Subindustry

of 235

Rank

Percentile

To view Guangzhou Wondfo Biotech’s complete esg history, request access »

Guangzhou Wondfo Biotech Exits (1)

Guangzhou Wondfo Biotech’s most recent exit was on 23-Jan-2017 from Binx. The exit was categorized as with 9 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Binx 23-Jan-2017 Completed
  • 9 buyers
To view Guangzhou Wondfo Biotech’s complete exits history, request access »

Guangzhou Wondfo Biotech Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Baishikang Biological Technology Ningbo, China 2017

Guangzhou Wondfo Biotech FAQs

  • When was Guangzhou Wondfo Biotech founded?

    Guangzhou Wondfo Biotech was founded in 1992.

  • Where is Guangzhou Wondfo Biotech headquartered?

    Guangzhou Wondfo Biotech is headquartered in Guangzhou, China.

  • What is the size of Guangzhou Wondfo Biotech?

    Guangzhou Wondfo Biotech has 2,443 total employees.

  • What industry is Guangzhou Wondfo Biotech in?

    Guangzhou Wondfo Biotech’s primary industry is Other Healthcare Technology Systems.

  • Is Guangzhou Wondfo Biotech a private or public company?

    Guangzhou Wondfo Biotech is a Public company.

  • What is Guangzhou Wondfo Biotech’s stock symbol?

    The ticker symbol for Guangzhou Wondfo Biotech is 300482.

  • What is the current stock price of Guangzhou Wondfo Biotech?

    As of 20-Nov-2026 the stock price of Guangzhou Wondfo Biotech is $2.15.

  • What is the current market cap of Guangzhou Wondfo Biotech?

    The current market capitalization of Guangzhou Wondfo Biotech is $1.01B.

  • What is Guangzhou Wondfo Biotech’s current revenue?

    The trailing twelve month revenue for Guangzhou Wondfo Biotech is $285M.

  • What is Guangzhou Wondfo Biotech’s annual earnings per share (EPS)?

    Guangzhou Wondfo Biotech’s EPS for 12 months was -$0.02.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process